CTOs on the Move

Lasergen

www.lasergen.com

 
Lasergen is an emerging biotechnology company focused on commercializing novel technologies for DNA sequencing. Our expertise in nucleotide chemistry and next-generation sequencing has led to a number of key discoveries resulting in both game-changing sequencing chemistry (Lightning Terminators™) and a more accurate sequencing platform. While focusing on the development of current cutting-edge technology, our continued drive for innovation and extensive sequencing knowledge allows us to rapidly evolve and keep pace with fast-changing advances in the sequencing industry.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Lasergen raised $80M on 03/07/2016

Similar Companies

Koya

Koya Medical is a transformative healthcare venture with a mission to treat cancer-related chronic lymphedema and venous diseases through innovative patient-centric platforms.

Lingualcare

Lingualcare is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

New England Brace Company

New England Brace Company is a Manchester, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nature’s Medicines

Whether you`re new to the wonders of cannabis, or a longtime connoisseur, Nature`s Medicines is here to guide you. Our number one goal is to inspire you on your personal self-care journey - and educate you along the way.

GT Medical Technologies

Driven to raise the standard of care and improve the lives of patients with brain tumors, a team of brain tumor specialists formed GT Medical Technologies. FDA-cleared GammaTile Therapy is a Surgically Targeted Radiation Therapy (STaRT) for patients undergoing brain tumor removal surgery of newly diagnosed malignant and recurrent brain tumors. This "one-and-done" treatment eliminates the need for one to six weeks of daily external beam radiation therapy, allowing patients to go about their daily lives without the burden of additional trips to the hospital or clinic for ongoing treatment. Since its full market release in the United States in March 2020, GammaTile has been offered in more than 95 hospitals, with more centers being added each month.